Literature DB >> 21460810

Prostate cancer: Active surveillance for low-risk disease: who will benefit most?

Nick Warde.   

Abstract

Entities:  

Year:  2011        PMID： 21460810     DOI： 10.1038/nrurol.2010.243

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  2 in total

1.  Role of prostate specific antigen and immediate confirmatory biopsy in predicting progression during active surveillance for low risk prostate cancer.

Authors:  Ari Adamy; David S Yee; Kazuhito Matsushita; Alexandra Maschino; Angel Cronin; Andrew Vickers; Bertrand Guillonneau; Peter T Scardino; James A Eastham
Journal:  J Urol       Date:  2010-12-17       Impact factor: 7.450

2.  Risk stratification and validation of prostate specific antigen density as independent predictor of progression in men with low risk prostate cancer during active surveillance.

Authors:  Ignacio F San Francisco; Lillian Werner; Meredith M Regan; Marc B Garnick; Glenn Bubley; William C DeWolf
Journal:  J Urol       Date:  2010-12-17       Impact factor: 7.450
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.